R K Johnson, E A Swyryd, G R Stark. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AnimalsAntimetabolites, Antineoplastic/therapeutic useAntimetabolites, Antineoplastic/toxicityAspartate Carbamoyltransferase/antagonists & inhibitorsAspartate Carbamoyltransferase/metabolismAspartic Acid/analogs & derivativesAspartic Acid/therapeutic useAspartic Acid/toxicityCells, CulturedCyclophosphamide/therapeutic useDrug Evaluation, PreclinicalGlioma/drug therapyGlioma/enzymologyGraft RejectionLeukemia, Experimental/drug therapyLung Neoplasms/drug therapyLung Neoplasms/enzymologyMelanoma/drug therapyMelanoma/enzymologyMiceMice, Inbred C57BLMice, Inbred DBANeoplasm TransplantationNeoplasms, Experimental/drug therapyNeoplasms, Experimental/enzymologyOrganophosphorus Compounds/therapeutic usePhosphonoacetic Acid/analogs & derivativesPhosphonoacetic Acid/therapeutic usePhosphonoacetic Acid/toxicity
Substances: See more » Antimetabolites, AntineoplasticOrganophosphorus CompoundsAspartic Acidsparfosic acidCyclophosphamideAspartate CarbamoyltransferasePhosphonoacetic Acid
Year: 1978 PMID: 620408
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701